Caricamento...
Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
Adriamycin (ADR) is an important chemotherapy agent in many advanced cancers, but the emergence of drug resistance during treatment is a major limitation to its successful use. Recent studies have suggested that drug-resistant cells become less fit and their growth could be inhibited by parental cel...
Salvato in:
| Pubblicato in: | Open Life Sci |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
De Gruyter
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874629/ https://ncbi.nlm.nih.gov/pubmed/33817298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2021-0004 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|